Use HCQ as per guidelines, its benefits outweighs risks: Niti Aayog member
(WorldNews India)

New Delhi: As per the current available data, benefits of anti-malarial drug Hydroxychroloquine (HCQ) `outweighs` the risks, if any, Niti Aayog member V K Paul said on Thursday, asserting it should be used as per guidelines and recommendations made by the scientific community. The drug has been recommended by the Indian Council of Medical Research (ICMR) as prophylaxis for COVID-19 among healthcare and frontline workers, and also for clinical management of patients, he said. Responding to a question over the government`s stand on the use of HCQ in COVID-19 cases after the WHO temporarily suspended its use in the clinical trials citing safety concerns, Paul said it can be used as per the...